KaloBios (KBIO) Stock Slammed after CEO Shkreli Arrested for Securities Fraud
November 29, 2015 at 19:00 PM EST
Shares of KaloBios Pharmaceutical Inc. (KBIO) were trading down -11.84 or -50.19 percent to $11.75 per share in Thursday's premarket after news that KaloBios Chief Executive, Martin Shkreli was arrested on securities fraud charges by federal agents at his home in New York early this morning. KaloBios stock closed at $23.59, down -1.265 or -5.09 ... READ MORE Read the rest of KaloBios (KBIO) Stock Slammed after CEO Shkreli Arrested for Securities Fraud at InvestorGuide.com .
